CQ Prescription Weight Loss Clinic

Service Description

Semaglutide ( Ozempic / Wegovy ) & Tirzepatide ( Mounjaro / Zepbound ) at CQ Semaglutide ( Ozempic / Wegovy ) is an FDA approved once a week injectable prescription weight loss medication and one of the two most effective weight loss prescription available today. Semaglutide is the active injectable glucagon-like peptide-1 (GLP-1) agonist contained in the following different brand name GLP-1 medications: Ozempic, Rybelsus, Wegovy. Compared to other medications, research shows Semaglutide helps patients lose more weight. CQ provides careful monitoring by our physicians with individualized adjustments to reach the target dose, at which stage the weight loss results are undeniable. This is typically managed by slowly increasing your dose over time and should only be prescribed and monitored by a licensed physician. Semaglutide is a FDA approved prescription medication originally used to treat Type 2 Diabetes Mellitus and then subsequently for weight loss management administered once weekly by easy subcutaneous injection. Tirzepatide ( Mounjaro / Zepbound ) like Ozempic's semaglutide are both in the class of drugs known as incretin mimetics but have some differences. Mounjaro acts on both GIP and GLP-1 receptors, while semaglutide acts only on GLP-1 receptors. Tirzepatide activates glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptors creating the most effective weight loss medication to date.  Book an appointment to schedule a free comprehensive weight loss consultation with our board-certified doctor at the CQ Med Gym Physician Prescription Weight Loss Clinic to lose weight successfully with the most advanced treatments.

Contact Details

• 31341 Niguel Road, Laguna Niguel, CA, USA